XML 82 R64.htm IDEA: XBRL DOCUMENT v3.20.2
Reportable Segments and Major Concentration Data - Segment Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Segment Reporting Information [Line Items]                      
Net revenues $ 64,153 $ 84,797 $ 57,296 $ 47,421 $ 50,846 $ 48,440 $ 50,248 $ 51,480 $ 253,667 $ 201,014 $ 213,571
Operating income                 61,324 32,699 31,584
Depreciation and amortization                 13,567 9,964 8,688
Capital expenditures                 3,299 3,797 4,201
Goodwill 114,186       89,241       114,186 89,241 54,637
Other intangible assets 83,197       60,243       83,197 60,243 23,113
Total assets 405,261       325,478       405,261 325,478 251,377
Restructuring and litigation costs                 2,080 2,596 7,779
Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 121,132 136,682 150,454
Life Science [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 132,535 64,332 63,117
Corporate [Member]                      
Segment Reporting Information [Line Items]                      
Operating income                 (11,437) (10,373) (15,076)
Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Operating income                   101 292
Total assets (34)       (83)       (34) (83) 58
Net revenues                 (587) (823) (789)
Operating Segments [Member] | Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 121,132 136,682 150,454
Operating income                 3,885 25,390 34,603
Depreciation and amortization                 11,451 7,676 6,557
Capital expenditures                 1,850 2,049 2,477
Goodwill 94,855       70,395       94,855 70,395 35,213
Other intangible assets 83,179       59,807       83,179 59,807 22,068
Total assets 306,812       255,169       306,812 255,169 180,978
Net revenues                 326 462 392
Operating Segments [Member] | Life Science [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 132,535 64,332 63,117
Operating income                 68,826 17,581 11,765
Depreciation and amortization                 2,116 2,288 2,131
Capital expenditures                 1,449 1,748 1,724
Goodwill 19,331       18,846       19,331 18,846 19,424
Other intangible assets 18       436       18 436 1,045
Total assets $ 98,483       $ 70,392       98,483 70,392 70,341
Net revenues                 $ 261 $ 361 $ 397